Literature DB >> 1087569

Practolol and ocular toxicity. Antibodies in serum and tears.

A Garner, A H Rahi.   

Abstract

Serological studies in 22 patients presenting with ocular disease attributable to dosage with the beta-blocking agent practolol revealed a raised incidence of antinuclear antibodies. There was also a marginal increase in the incidence of antibodies to smooth muscle in the more severely affected individuals but the incidence of ther autoantibodies and levels of IgG, IgA, and IgM were within normal limits. Semi-quantitative analysis of tears from 14 of the patients showed absence or near absence in the more severely affected patients of secretory IgA, which is indicative of damage to the lacrimal gland. Other immunological parameters in the tears were normal.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087569      PMCID: PMC1042809          DOI: 10.1136/bjo.60.10.684

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  5 in total

1.  Untoward effects associated with practolol: demonstration of antibody binding to epithelial tissue.

Authors:  H E Amos; W D Brigden; R A McKerron
Journal:  Br Med J       Date:  1975-03-15

2.  Cutaneous and ocular reactions to practolol.

Authors:  R H Felix; F A Ive; M G Dahl
Journal:  Br Med J       Date:  1974-11-09

3.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

4.  Practolol-induced drug eruption.

Authors:  E S Assem; R A Banks
Journal:  Proc R Soc Med       Date:  1973-02

5.  Pathology of practolol-induced ocular toxicity.

Authors:  A H Rahi; C M Chapman; A Garner; P Wright
Journal:  Br J Ophthalmol       Date:  1976-05       Impact factor: 4.638

  5 in total
  4 in total

1.  Effects of timolol on corneal sensitivity and tear production.

Authors:  Y Kitazawa; H Tsuchisaka
Journal:  Int Ophthalmol       Date:  1980-12       Impact factor: 2.031

Review 2.  Antinuclear antibodies and cardiovascular drugs.

Authors:  J D Wilson
Journal:  Drugs       Date:  1980-04       Impact factor: 9.546

3.  Immunoglobulin concentrations in human tears in ocular diseases.

Authors:  D K Sen; G S Sarin
Journal:  Br J Ophthalmol       Date:  1979-05       Impact factor: 4.638

4.  Importance of Publishing Adverse Drug Reaction Case Reports: Promoting Public Health and Advancing Pharmacology and Therapeutics.

Authors:  Rashmi R Shah
Journal:  Drug Saf Case Rep       Date:  2017-09-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.